Guardian Asset Advisors’s AbbVie ABBV Stock Holding History

Guardian Asset Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$887K	Sell	3,528 -494	-12%	-$106K	0.41%	52
2026 Q1	$875K	Buy	4,022 +166	+4%	+$36.8K	0.51%	41
2025 Q4	$882K	Sell	3,856 -84	-2%	-$19.1K	0.46%	47
2025 Q3	$912K	Sell	3,940 -914	-19%	-$186K	0.49%	45
2025 Q2	$901K	Buy	4,854 +29	+0.6%	+$5.39K	0.52%	43
2025 Q1	$1.01M	Buy	4,825 +491	+11%	+$95.5K	0.66%	35
2024 Q4	$771K	Sell	4,334 -247	-5%	-$45.4K	0.49%	40
2024 Q3	$905K	Sell	4,581 -60	-1%	-$11.2K	0.61%	35
2024 Q2	$796K	Sell	4,641 -88	-2%	-$14.6K	0.58%	36
2024 Q1	$861K	Buy	4,729 +87	+2%	+$15K	0.71%	33
2023 Q4	$720K	Buy	+4,642	New	+$677K	0.68%	32

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Guardian Asset Advisors's ABBV Position: Q2 2026 in Review

Guardian Asset Advisors reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $106K and leaving 3,528 shares worth $887K. The position accounts for 0.41% of the portfolio, ranked #52.

Guardian Asset Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.01M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Guardian Asset Advisors held 3,528 shares of AbbVie worth $887K as of Q2 2026.
Guardian Asset Advisors sold 494 AbbVie shares in Q2 2026, an estimated $106K.
AbbVie made up 0.41% of Guardian Asset Advisors's portfolio in Q2 2026, its #52 holding.
Guardian Asset Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Guardian Asset Advisors's AbbVie position peaked at $1.01M in Q1 2025.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guardian Asset Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.